ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,000 | +300.0% | 1,930 | +589.3% | 0.00% | – |
| Q2 2023 | $1,000 | -80.0% | 280 | -85.3% | 0.00% | – |
| Q1 2023 | $5,000 | -70.6% | 1,903 | -63.8% | 0.00% | – |
| Q4 2022 | $17,000 | +70.0% | 5,257 | +48.5% | 0.00% | – |
| Q3 2022 | $10,000 | +400.0% | 3,540 | +621.0% | 0.00% | – |
| Q2 2022 | $2,000 | -98.6% | 491 | -95.4% | 0.00% | – |
| Q1 2022 | $143,000 | -56.9% | 10,617 | -58.3% | 0.00% | – |
| Q4 2021 | $332,000 | -65.1% | 25,462 | -74.9% | 0.00% | – |
| Q3 2021 | $952,000 | -39.9% | 101,513 | -34.4% | 0.00% | – |
| Q2 2021 | $1,585,000 | -34.7% | 154,739 | +17.2% | 0.00% | -100.0% |
| Q1 2021 | $2,429,000 | -8.8% | 131,995 | +69.8% | 0.00% | 0.0% |
| Q4 2020 | $2,663,000 | +424.2% | 77,747 | +182.7% | 0.00% | – |
| Q3 2020 | $508,000 | – | 27,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |